Literature DB >> 7614976

Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in nephrotic syndrome.

H Kimata1, M Fujimoto, K Furusho.   

Abstract

Nephrotic syndrome (NS) is a renal disease characterized by proteinuria and hypoalbuminemia. In NS patients without any allergic disease, serum IgE and IgG4 levels were selectively increased, and peripheral blood mononuclear cells (MNC) spontaneously produced IgE and IgG4. T cells produced interleukin (IL)-13 spontaneously, and B cells constitutively expressed IL-13 receptors (IL-13R). In addition, T cells stimulated surface IgE-negative (sIgE-) and sIgG4- B cells to produce IgE and IgG4, respectively, and IgE and IgG4 production was specifically blocked by anti-IL-13 antibody (Ab). MNC from atopic dermatitis (AD) patients also produced IgE and IgG4 spontaneously. However, in AD patients, T cells spontaneously produced IL-4, but not IL-13, and B cells constitutively expressed IL-4R, but not IL-13R. T cells stimulated sIgE- and sIgG4- B cells to produce IgE and IgG4, respectively, and the production was specifically blocked by anti-IL-4 Ab. On the other hand, sIgE+ and sIgG4+ B cells from both NS and AD patients spontaneously produced IgE and IgG4, respectively, and this production was not affected by T cells, anti-IL-4 Ab, or anti-IL-13 Ab. These results indicate that IL-13 is involved in the enhanced production of IgE and IgG4 in NS, while IL-4 is involved in these responses in AD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614976     DOI: 10.1002/eji.1830250604

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  26 in total

1.  Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes.

Authors:  Tomohito Gohda; William H Walker; Pawel Wolkow; Jung Eun Lee; James H Warram; Andrzej S Krolewski; Monika A Niewczas
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-18

Review 2.  [Minimal change disease and focal segmental glomerulosclerosis].

Authors:  J Müller-Deile; H Schenk; M Schiffer
Journal:  Internist (Berl)       Date:  2019-05       Impact factor: 0.743

3.  Risk of idiopathic nephrotic syndrome among children with asthma: a nationwide, population-based cohort study.

Authors:  Chang-Ching Wei; Cheng-Li Lin; Te-Chun Shen; Yu-Fen Li
Journal:  Pediatr Res       Date:  2015-04-30       Impact factor: 3.756

Review 4.  Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes.

Authors:  Kazunari Kaneko; Shoji Tsuji; Takahisa Kimata; Tetsuya Kitao; Sohsaku Yamanouchi; Shogo Kato
Journal:  World J Pediatr       Date:  2015-01-28       Impact factor: 2.764

5.  Characterisation of renal immune cell infiltrates in children with nephrotic syndrome.

Authors:  Kerstin Benz; Maike Büttner; Katalin Dittrich; Valentina Campean; Jörg Dötsch; Kerstin Amann
Journal:  Pediatr Nephrol       Date:  2010-04-13       Impact factor: 3.714

6.  The role of IL-13 in IgE synthesis by allergic asthma patients.

Authors:  T C Van der Pouw Kraan; J S Van der Zee; L C Boeije; E R De Groot; S O Stapel; L A Aarden
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

7.  Implication of serum IgE in childhood nephrotic syndrome.

Authors:  You-Lin Tain; Tsung-Yi Chen; Kuender D Yang
Journal:  Pediatr Nephrol       Date:  2003-10-31       Impact factor: 3.714

8.  Antibody status in children with steroid-sensitive nephrotic syndrome.

Authors:  Ji-Whan Han; Kyung-Yil Lee; Ja-Young Hwang; Dea-Kyun Koh; Joon-Sung Lee
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

9.  Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome.

Authors:  Xiao-Ling Niu; Sheng Hao; Ping Wang; Wei Zhang; Gui-Mei Guo; Ying Wu; Xin-Yu Kuang; Guang-Hua Zhu; Wen-Yan Huang
Journal:  Biomed Rep       Date:  2016-06-30

10.  Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children.

Authors:  Koichi Kamei; Shuichi Ito; Kandai Nozu; Shuichiro Fujinaga; Makiko Nakayama; Mayumi Sako; Mari Saito; Maki Yoneko; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2009-05-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.